广东全省中医药管理工作者集中培训,一起为中医药法打call!

2017-11-22 朱蕗鋆 中国中医

为贯彻落实党的十九大精神,切实提高运用法治思维和法治方式推动中医药振兴发展的能力,11月15日,广东省举行全省宣传贯彻中医药法及《广东省岭南中药材保护条例》培训班。

为贯彻落实党的十九大精神,切实提高运用法治思维和法治方式推动中医药振兴发展的能力,11月15日,广东省举行全省宣传贯彻中医药法及《广东省岭南中药材保护条例》培训班。

国家中医药管理局政策法规与监督司负责人,广东省人大常委会有关领导,省卫生计生委、省中医药局领导等出席开班仪式。广东省中医药局干部职工,省属中医医院、21个地市、121个县(区)和知名中医药企业共200多名代表参加学习。培训班主题鲜明,内容丰富。国家中医药管理局政策法规与监督司负责人对中医药法及其配套文件作全面解读,广东省卫生计生委、省中医药局领导,有关专家学者作专题讲座。

据悉,中医药法颁布实施以来,广东省中医药系统把贯彻实施中医药法作为今年的一项重要工作,深入开展中医药法的学习宣传、贯彻实施,取得诸多成效。一是迅速启动《广东省发展中医条例》的修订工作。广东省中医药局积极配合省人大常委会开展中医药法治化建设调研座谈等前期准备工作,目前修订工作已纳入省人大2018年立法计划。二是创新社会办医新模式,积极推进中医连锁医疗机构发展,《广东省连锁中医医疗机构管理试行办法》及《广东省连锁中医医疗机构基本标准》(试行)即将出台。三是将出台《广东省岭南中药材保护条例释义》,更好地运用法律从种源、产地、种植、品牌到加工全方位加强对岭南地道中医药材的保护。四是积极发挥中医药强省建设联席会议制度作用,积极协调省人大,将中医药法贯彻落实情况纳入人大监督体系,加大对各地落实中医药法的督导力度。五是压实地方责任,积极协调将中医药法贯彻落实情况列入全省卫生计生考核项目。六是加快建立完善中医药监督执法体制机制。本月即将举办第三期全省中医药监督知识与能力培训班,之前已累计培训400名卫生监督员,监督执法力量不断加强。七是开展微信学法。在广东中医药官方微信开通政策法规专栏,方便各级中医药工作者随时随地查询法律条文,推动全系统人人学法、人人懂法。

广东省卫生计生委副主任、省中医药局局长徐庆锋要求大家认真学习贯彻党的十九大精神,以本次培训班为契机,掀起全省学习宣传贯彻《中华人民共和国中医药法》的高潮,层层发动、层层落实,推进中医药强省建设,助力建设健康广东。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656316, encodeId=a03416563169f, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Feb 26 08:34:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803847, encodeId=112a180384eb1, content=<a href='/topic/show?id=906ee6033e8' target=_blank style='color:#2F92EE;'>#管理工作者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76033, encryptionId=906ee6033e8, topicName=管理工作者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Feb 25 02:34:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329038, encodeId=c5db13290385d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409203, encodeId=ecf61409203f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263731, encodeId=5104263e31f6, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:59 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656316, encodeId=a03416563169f, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Feb 26 08:34:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803847, encodeId=112a180384eb1, content=<a href='/topic/show?id=906ee6033e8' target=_blank style='color:#2F92EE;'>#管理工作者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76033, encryptionId=906ee6033e8, topicName=管理工作者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Feb 25 02:34:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329038, encodeId=c5db13290385d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409203, encodeId=ecf61409203f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263731, encodeId=5104263e31f6, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:59 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656316, encodeId=a03416563169f, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Feb 26 08:34:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803847, encodeId=112a180384eb1, content=<a href='/topic/show?id=906ee6033e8' target=_blank style='color:#2F92EE;'>#管理工作者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76033, encryptionId=906ee6033e8, topicName=管理工作者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Feb 25 02:34:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329038, encodeId=c5db13290385d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409203, encodeId=ecf61409203f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263731, encodeId=5104263e31f6, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:59 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-24 膀胱癌
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656316, encodeId=a03416563169f, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Feb 26 08:34:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803847, encodeId=112a180384eb1, content=<a href='/topic/show?id=906ee6033e8' target=_blank style='color:#2F92EE;'>#管理工作者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76033, encryptionId=906ee6033e8, topicName=管理工作者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Feb 25 02:34:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329038, encodeId=c5db13290385d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409203, encodeId=ecf61409203f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263731, encodeId=5104263e31f6, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:59 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-24 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1656316, encodeId=a03416563169f, content=<a href='/topic/show?id=13042154579' target=_blank style='color:#2F92EE;'>#中医药法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21545, encryptionId=13042154579, topicName=中医药法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1024785457, createdName=hmwwww, createdTime=Mon Feb 26 08:34:00 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1803847, encodeId=112a180384eb1, content=<a href='/topic/show?id=906ee6033e8' target=_blank style='color:#2F92EE;'>#管理工作者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76033, encryptionId=906ee6033e8, topicName=管理工作者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sun Feb 25 02:34:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329038, encodeId=c5db13290385d, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409203, encodeId=ecf61409203f0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 24 09:34:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263731, encodeId=5104263e31f6, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:59 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-23 thlabcde

    好资料学习了!

    0

相关资讯

全科医生设特岗!给编制,一年补6万!

按照报告的规划,未来在加强基层医疗能力的过程中,全科医生必将是一个重要的鼓励岗位,基层医生转岗全科医生,会是一个很有前景的选择。

粤未来两年207亿投向县以下医疗卫生机构

9日下午,广东省人大常委会副主任陈继兴率部分省人大代表到省财政厅视察,并提前介入省级加强基层医疗卫生服务能力建设资金和普通公路国省道建设资金预算编制。记者在会上获悉,2017年—2019年,省级财政安排309亿元加强县级以下医疗卫生机构的硬件和软件,今年已拨付101.41亿元,接下来两年拟继续拨付207.59亿元。这些资金将用于45家中心卫生院、18家县级中医院、196家县办公立医院的升级建设,4

广东放大招 医生违反医保规定影响工资和晋升

日前,广东省人社厅公开征求《关于进一步加强基本医疗保险基金安全监管的意见(征求意见稿)》的意见(下简称《意见》)。《意见》明确,建立全省互通的医药机构诚信档案,建立医药机构、医务人员黑名单,推广人脸识别技术,强化监督执法、加大案件查处移送力度等。微信截图_20171108170704.png医疗机构累计3次被暂停协议 1年内不得重新签订《意见》要求完善医疗机构服务协议,加强监督和考核,将考核结

广东鼓励有条件高校试办中医药健康服务学院,设中医养生专业

鼓励有条件的高校试办中医药健康服务学院;推进老中医药专家学术经验传承,加快推进中医药高层次人才培养……这是广东省政府办公厅近日印发的关于《广东省深化医教协同进一步推进医学教育改革与发展实施方案》的通知中披露的内容。《国务院办公厅关于深化医教协同进一步推进医学教育改革与发展的意见》今年7月印发。日前广东结合省情实际,制订了实施方案。对于社会较关心的如何加强中医药人才培养,促进中医药事业发展问题。广东

世界首例 广东医生新技术能让卵子变年轻

梁晓燕教授:这项技术可以理解为,卵细胞差一口气就可以跑到终点成功受精,线粒体的注入推了它一把。胚胎.jpg中山六院生殖中心的医生在显微注射仪下进行胚胎操作 周巍/摄胚胎质量是试管婴儿成功与否的重要原因,胚胎质量越好,成功率越高。临床上,至少有10%的患者因为胚胎质量不好,反复做试管婴儿治疗却始终不成功。她们要么是高龄产妇,卵子老化;要么是卵子质量不好,无法成功妊娠。如今,这一难题有了新突破。11月

广东:鼓励有条件的高校试办中医药健康服务学院

新华社电(记者周颖)  鼓励有条件的高校试办中医药健康服务学院;推进老中医药专家学术经验传承,加快推进中医药高层次人才培养……这是广东省政府办公厅近日印发的关于《广东省深化医教协同进一步推进医学教育改革与发展实施方案》的通知中披露的内容。